Dipeptidyl peptidase 4 inhibition ameliorates hypertension via normalizing preload through the RAAS axis

被引：0
|
作者：
Kawase, H. [1 ]
Bando, Y. Kureishi [1 ]
Aoyama, M. [1 ]
Murohara, T. [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5181
引用
收藏
页码：913 / 913
页数：1
相关论文
共 50 条
  • [1] Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension
    Cappetta, Donato
    Ciuffreda, Loreta Pia
    Cozzolino, Anna
    Esposito, Grazia
    Scavone, Cristina
    Sapio, Luigi
    Naviglio, Silvio
    D'Amario, Domenico
    Crea, Filippo
    Rossi, Francesco
    Berrino, Liberato
    De Angelis, Antonella
    Urbanek, Konrad
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
  • [2] Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS Inhibition
    Wilson, Jessica R.
    Kerman, Scott Jafarian
    Hubers, Scott A.
    Yu, Chang
    Nian, Hui
    Grouzmann, Eric
    Eugster, Philippe J.
    Mayfield, Dustin S.
    Brown, Nancy J.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (10) : 1784 - 1798
  • [3] Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport
    Goto, Moritaka
    Furuta, Shinji
    Yamashita, Satoko
    Hashimoto, Hiroyuki
    Yano, Wataru
    Inoue, Noriyuki
    Kato, Noriaki
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (06) : 1261 - 1269
  • [4] Polyalthia Clerodane Diterpene Potentiates Hypoglycemia via Inhibition of Dipeptidyl Peptidase 4
    Huang, Po-Kai
    Lin, Shian-Ren
    Riyaphan, Jirawat
    Fu, Yaw-Syan
    Weng, Ching-Feng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
  • [5] Dipeptidyl peptidase IV inhibition ameliorates cardiorenal function in experimental heart failure
    Arruda-Junior, Daniel
    Socas, Leonardo
    Dariolli, Rafael
    Antonio, Ednei
    Tucci, Paulo
    dos Santos, Leonardo
    Girardi, Adriana
    FASEB JOURNAL, 2014, 28 (01):
  • [6] Dipeptidyl peptidase 4 inhibitor sitagliptin ameliorates renal function in a model of hypertension-induced cardiorenal disease
    Cappetta, D.
    De Angelis, A.
    Ciuffreda, L. P.
    Esposito, G.
    Cozzolino, A.
    D'amario, D.
    Siracusano, A.
    Rossi, F.
    Crea, F.
    Berrino, L.
    Urbanek, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 512 - 512
  • [7] Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition
    Nagakura, T
    Yasuda, N
    Yamazaki, K
    Ikuta, H
    Tanaka, I
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (01): : 81 - 86
  • [8] Extrapancreatic contribution to glucose regulation by dipeptidyl peptidase 4 inhibition
    Omar, Bilal A.
    Ahren, Bo
    CARDIOVASCULAR ENDOCRINOLOGY, 2016, 5 (03): : 82 - 85
  • [9] Effect of dipeptidyl peptidase-4 inhibition on complement activation
    Hoffmann-Petersen, Ingeborg
    Ostergaard, Jakob Appel
    Holt, Charlotte Berg
    Mellbin, Linda
    Thiel, Steffen
    Hansen, Troels Krarup
    MOLECULAR IMMUNOLOGY, 2015, 67 (01) : 144 - 144
  • [10] Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4
    Mishra, Avinash
    Cross, Megan
    Hofmann, Andreas
    Coster, Mark J.
    Karim, Abdul
    Sattar, Abdul
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2019, 26 (12) : 1470 - 1486
12345